Completed PHASE4 INTERVENTIONAL 2-arm NCT01853696

Comparison of Corticosteroid Dosing Regimens After Endothelial Keratoplasty

Prospective, Randomized Comparison of Corticosteroid Dosing Regimens Following Endothelial Keratoplasty

Sponsor: Cornea Research Foundation of America

Conditions Corneal Edema Fuchs' Dystrophy

Interventions loteprednol etabonate prednisolone acetate 1%

Updated 5 times since 2017 Last updated: Apr 29, 2015 Started: Mar 31, 2013 Primary completion: Jan 31, 2015 Completion: Jan 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01853696, this PHASE4 trial focuses on Corneal Edema and Fuchs' Dystrophy and remains completed. Sponsored by Cornea Research Foundation of America, it has been updated 5 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Mar 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cornea Research Foundation of America

Data source: Cornea Research Foundation of America

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Indianapolis, United States